Background
- Also known as pertussis
- Highly infectious disease caused by Bordatella pertussis
- Produces pertussis toxin
- Incubation usually around 7 days; spread via aerosol droplets; infectious for 3 weeks after initial symptoms
- Fortunately infrequent (1 in 1000 per year during ‘peak year’ which recur every 3-5 years) in the UK due to vaccination (DTaP at 2, 3, 4 months)
- More common in infants who have not yet received full vaccination (or unvaccinated)
Presentation
- 3 phases of infection
- catarrhal phase
- dry, unproductive cough; may be preceded by prodromal symptoms typical of URTI (up to 7 days)
- Paroxysmal phase
- whooping (inspiratory gasp- may not be seen in adults), post-tussive (cough) vomiting is common in infants, generalised symptoms (can last a month or more)
- between coughing fits, the patient is generally well
- coughing fits are more common at night, can be triggered by cold/noise
- in adults there may be associated autonomic features e.g. sweating, flushing; in children, it can cause cyanosis
- Convalescent phase
- Gradual improvement (can take 2+ months)
- catarrhal phase
-
NB Pertussis is a notifiable disease
Investigations
- Most cases are clinical diagnoses; but health protection may request laboratory confirmation via
- nasopharygeal aspirate/swab
- antipertussis toxin IgG
- PCR positive
Management
- Consider admission to those who are seriously unwell e.g. cyanotic, apnoea, trouble breathing
- Low threshold in infants <6 months
- Particularly in cases with complications e.g. pneumonia
- Consider antibiotic treatment (macrolide- clarithromycin in <1 month; azithromycin + clarithromycin in older infants/children/adults; erythromycin in pregnancy) if symptoms started within 21 days
- Important to treat in pregnancy to prevent transmission
- Health protection can consider offering antibiotic prophylaxis to those at risk (priority group) contacts e.g. those with pregnant women or baby in household. Also offer immunisation